Skip to main content
. 2017 Jun 23;12(6):e0179798. doi: 10.1371/journal.pone.0179798

Fig 5. KPC34 can be combined with a TKI.

Fig 5

Kaplan-Meier curves for C57/Bl6 mice injected with B6-ALL syngeneic leukemia. Upon engraftment mice were treated with saline (control), nilotinib at 75 mg/kg or KPC34 at 20 mg/kg daily for 4 days followed by nilotinib at 75 mg/kg. The p value shown was calculated by log-rank test.